Skip to main content

Your search for “Covid-19” returned 606 results

SDSC Team Models Potential SARS-CoV2 Protease Inhibitors for COVID-19

December 1, 2020

A team of SDSC researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19

UC San Diego Joins National Trial to Explore New Vaccines for COVID-19 Variants

April 6, 2022

UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine

October 1, 2020

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.

Researchers Continue Study of COVID-19 Vaccinations, Pregnancy and Postpartum

June 23, 2022

A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.

Giving Increased During the Pandemic in Areas Hit Hardest by COVID-19

April 4, 2022

Charitable giving increased in counties that experienced COVID-19-related deaths, reveals a new study from the University of California San Diego’s Rady School of Management published in Nature’s Scientific Reports.

Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia

March 1, 2021

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.

Statins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to Infect

September 23, 2020

Analyzing anonymized patient medical records, UC San Diego researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 infection, while lab experiments uncovered a cellular mechanism that helps explain why.

Transplant, Cancer Patients Among First to Get Evusheld at UC San Diego Health

March 21, 2022

UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

April 6, 2020

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

Researchers See an Increase in Fraudulent COVID-19 Posts on Social Media

August 25, 2020

In a new study from UC San Diego School of Medicine, thousands of fake social media posts tied to COVID-19 and financial scams are found on two popular platforms.

Category navigation with Social links